CVE-2026-62514: Oracle E-Business Suite Auth Bypass Flaw

CVE-2026-62514 Overview

CVE-2026-62514 is a high-severity access control vulnerability in the Oracle Process Manufacturing Regulatory Management product, part of Oracle E-Business Suite. The flaw resides in the Internal Operations component and affects supported versions 12.2.3 through 12.2.15. A low-privileged attacker with network access via HTTP can exploit this weakness without user interaction. Successful exploitation permits unauthorized creation, deletion, or modification of critical data, along with unauthorized read access to all data accessible by the module. The vulnerability is classified under CWE-284: Improper Access Control.

Critical Impact
Authenticated network attackers can read, modify, or delete all data accessible to Oracle Process Manufacturing Regulatory Management, compromising both confidentiality and integrity of regulated manufacturing records.

Affected Products

Oracle E-Business Suite - Oracle Process Manufacturing Regulatory Management (version 12.2.3)
Oracle E-Business Suite - Oracle Process Manufacturing Regulatory Management (versions 12.2.4 through 12.2.14)
Oracle E-Business Suite - Oracle Process Manufacturing Regulatory Management (version 12.2.15)

Discovery Timeline

2026-07-21 - Oracle publishes the vulnerability in the Oracle Security Alert July 2026
2026-07-21 - CVE-2026-62514 published to NVD
2026-07-22 - Last updated in NVD database

Technical Details for CVE-2026-62514

Vulnerability Analysis

CVE-2026-62514 is an improper access control weakness [CWE-284] within the Internal Operations component of Oracle Process Manufacturing Regulatory Management. The module fails to enforce sufficient authorization checks on HTTP-accessible operations. As a result, a user holding only low-privilege credentials can invoke functionality that should be restricted to higher-privileged roles.

The attack requires no user interaction and no elevated permissions beyond a valid low-privileged session. Because Oracle E-Business Suite is commonly deployed for regulated industries such as pharmaceuticals, food and beverage, and chemical manufacturing, the affected data often includes formulation records, regulatory submissions, and batch records subject to compliance frameworks including 21 CFR Part 11.

Oracle has not published exploit details. The EPSS probability is 0.296%, indicating a low but non-zero near-term exploitation likelihood based on current signals.

Root Cause

The root cause is missing or insufficient authorization enforcement on HTTP endpoints exposed by the Internal Operations component. The application trusts authenticated session context without verifying whether the caller holds the specific role or object-level permission required for the requested action. This design flaw allows lateral access to data and operations that fall outside the attacker's authorized scope.

Attack Vector

The attack vector is network-based (AV:N) over HTTP with low attack complexity. An authenticated attacker sends crafted HTTP requests to the vulnerable endpoints in the Regulatory Management module. Because the scope is unchanged and no user interaction is required, exploitation can be automated by any account able to reach the E-Business Suite web tier. The confidentiality and integrity impacts are rated High; availability is not affected.

No public proof-of-concept, exploit code, or in-the-wild exploitation has been confirmed. The vulnerability is not listed in the CISA Known Exploited Vulnerabilities catalog.

Detection Methods for CVE-2026-62514

Indicators of Compromise

Unexpected HTTP requests to Oracle Process Manufacturing Regulatory Management servlets or JSP endpoints originating from accounts with minimal assigned responsibilities.
Audit log entries in FND_LOG_MESSAGES or GMD_* regulatory tables showing create, update, or delete operations by users who typically do not perform such actions.
Anomalous session activity from low-privilege E-Business Suite accounts accessing regulatory formulation, batch, or submission records.

Detection Strategies

Correlate Oracle E-Business Suite application audit logs with web-tier access logs to identify low-privileged accounts invoking Regulatory Management operations outside their business role.
Baseline normal Regulatory Management activity per user and role, then alert on deviations such as bulk reads or writes by non-regulatory personnel.
Monitor database-level auditing on Process Manufacturing schemas (GMD, GMI, GR) for unauthorized data manipulation events.

Monitoring Recommendations

Enable and forward Oracle E-Business Suite Sign-On Audit and Page Access Tracking data to a centralized SIEM for behavioral analytics.
Track HTTP POST and PUT requests to Regulatory Management URIs and alert on unusual volume or off-hours activity.
Review Oracle Fine-Grained Auditing (FGA) policies to ensure sensitive regulatory tables are covered and alerts are actionable.

How to Mitigate CVE-2026-62514

Immediate Actions Required

Apply the July 2026 Oracle Critical Patch Update to all affected Oracle E-Business Suite installations running versions 12.2.3 through 12.2.15.
Inventory all accounts with access to the Oracle Process Manufacturing Regulatory Management module and remove unused or over-provisioned responsibilities.
Restrict network access to the E-Business Suite web tier to trusted internal networks and VPN endpoints only.

Patch Information

Oracle addressed CVE-2026-62514 in the July 2026 Critical Patch Update. Administrators should reference the Oracle Security Alert July 2026 for patch identifiers, prerequisites, and post-installation validation steps. Apply patches in a non-production environment first and validate regulatory reporting functionality before production rollout.

Workarounds

Reduce role assignments so that only regulatory personnel hold responsibilities that grant access to the Process Manufacturing Regulatory Management module.
Deploy a web application firewall rule set that restricts access to Regulatory Management endpoints by source IP and user identity where feasible.
Increase audit granularity on Process Manufacturing schemas and require documented approval for any operational changes until patching is complete.

bash

# Example: restrict access to E-Business Suite Regulatory Management URIs at the reverse proxy
# (adjust paths to match your deployment)
location ~* /OA_HTML/.*GMD.* {
    allow 10.0.0.0/8;         # internal regulatory network
    deny  all;
    proxy_pass http://ebs-backend;
}